Target General Information
Target ID T54902
Target Name MHC class I NK cell receptor
Synonyms CD158 antigenlike family member B1; Killer cell immunoglobulinlike receptor 2DL2; MHC class I NK cell receptor; NKAT6; Natural killerassociated transcript 6; p58 NK receptor CL43; p58 natural killer cell receptor clone CL43; KIR2DL2
Target Type Clinical Trial
Gene Name KIR2DL2
Biochemical Class Immunoglobulin
UniProt ID KI2L2_HUMAN
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals
Disease Myeloma
Example drug mab 1-7F9 Phase 2 [530228], [530238], [1572592]
Tissue Bone marrow
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual Fold-change: -0.93
Z-score: -3.58
P-value: 1.69E-05
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
Disease Acute myelocytic leukemia
Tissue Bone marrow
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual Fold-change: -0.58
Z-score: -1.03
P-value: 5.32E-23
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
Target Gene Expression Profiles in Other Tissues of Healthy Individuals
Reference
Ref
Ref 530228Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells. Blood. 2009 Sep 24;114(13):2667-77.
Ref 530238Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo. Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12879-84.
Ref 1572592NCBI GEO: archive for functional genomics data sets--update.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.